Anbieter: books4less (Versandantiquariat Petra Gros GmbH & Co. KG), Welling, Deutschland
Erstausgabe
Hardcover-Großformat. Zustand: Gut. 1. Ed. 440 Seiten; Der Erhaltungszustand des hier angebotenen Werks ist trotz seiner Bibliotheksnutzung sehr sauber. Es befindet sich neben dem Rückenschild lediglich ein Bibliotheksstempel im Buch; ordnungsgemäß entwidmet. Sprache: Englisch Gewicht in Gramm: 1140.
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
EUR 189,99
Anzahl: 1 verfügbar
In den WarenkorbZustand: Used. pp. 464 Illus.
Zustand: Used. pp. 464.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 228,55
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
EUR 246,91
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In Glutamate and Addiction, world-renowned scientific experts critically review all of the evidence for the role of glutamatergic systems in opiate, stimulant, and alcohol addiction. Using a variety of pharmacological, biochemical, genetic, and brain imagin.
Zustand: New. Reviews the role of glutamatergic systems in opiate, stimulant, and alcohol addiction. Using the pharmacological, biochemical, genetic, and brain imaging techniques, this book shows how glutamate affects such addictions and how modifying certain elements of the glutamatergic system appear to alleviate particular components of addiction. Series: Contemporary Clinical Neuroscience. Num Pages: 440 pages, biography. BIC Classification: MMGT. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 253 x 178 x 25. Weight in Grams: 1017. . 2002. Hardback. . . . . Books ship from the US and Ireland.
Sprache: Englisch
Verlag: Springer Nature B.V. Aug 2002, 2002
ISBN 10: 0896038793 ISBN 13: 9780896038790
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Neuware - In Glutamate and Addiction, world-renowned scientific experts critically review all of the evidence for the role of glutamatergic systems in opiate, stimulant, and alcohol addiction. Using a variety of pharmacological, biochemical, genetic, and brain imaging techniques, these investigators show precisely how glutamate affects such addictions and how modifying certain elements of the glutamatergic system appear to alleviate particular components of addiction. Their survey takes in both clinical approaches using medications that influence glutamate and cutting-edge preclinical approaches that manipulate specific subtypes of glutamate receptors or specific substrates of the 'glutamate cascade' to determine their roles in various addictive states.